CELLNOVO
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition. The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.
CELLNOVO
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2002-01-01
Address:
Wales, Cumbria, United Kingdom
Country:
United Kingdom
Total Employee:
51+
Status:
Closed
Contact:
44 20 3058 1250
Email Addresses:
[email protected]
Total Funding:
102.54 M USD
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - CellNovo
Kreos Capital
Kreos Capital investment in Post-IPO Debt - CellNovo
Nesta Ventures
Nesta Ventures investment in Series B - CellNovo
Andera Partners
Andera Partners investment in Series B - CellNovo
HealthCare Ventures
HealthCare Ventures investment in Series B - CellNovo
Omnes Capital
Omnes Capital investment in Series B - CellNovo
Advent Venture Partners
Advent Venture Partners investment in Series B - CellNovo
Auriga Partners
Auriga Partners investment in Series B - CellNovo
Forbion Capital Partners
Forbion Capital Partners investment in Series B - CellNovo
NBGI Ventures
NBGI Ventures investment in Series B - CellNovo
More informations about "CellNovo"
CellNovo - Crunchbase Company Profile & Funding
. When was the last funding round for CellNovo? CellNovo closed its last funding round on Jul 10, 2017 from a Post-IPO Debt round. Who are CellNovo's …See details»
Cellnovo | Advent Life Sciences
The Cellnovo system is the world’s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated blood glucose meter and automatic …See details»
Cellnovo 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Cellnovo. Use the PitchBook Platform to explore the full profile.See details»
Cellnovo - Forbion
Cellnovo Insulin patch pump that helps make life easier for diabetics type 1. The Cellnovo System is the world’s first mobile diabetes management system, …See details»
Organization: Cellnovo Group - Cbonds.com
Cellnovo Group. Information about the issuer. News and credit ratings. (LEI 969500NDCP5QIL1QO961). Tables with accounting and financial reporting.See details»
The Cellnovo Insulin Delivery System - PMC
What makes the Cellnovo system different to other insulin delivery devices? It is different because it is the first mobile diabetes management system, providing intuitive operation, internet …See details»
Cellnovo to cease producing its insulin pumps and technology
Mar 29, 2019 Cellnovo, a company that made innovative insulin pump and diabetes management systems, has announced it will cease production of its systems. The company, …See details»
Cellnovo (Group) - life-sciences-usa.com
An international commercial medical technology company, Cellnovo markets the first mobile, connected all-in-one diabetes management system, a disruptive technology enhancing daily …See details»
Cellnovo Group - Biotechnology, Health Care Company Profile, …
Cellnovo Group, with the slogan "The first connected diabetes management platform," is an innovative medical technology company founded in 2002. The company specializes in …See details»
Cellnovo Group S.A - DevelopmentAid
Cellnovo is an innovative medical technology company specialising in diabetes. The company develops and markets The Cellnovo System, the world's first mobile, connected, all-in-one …See details»
Cellnovo - 2025 Company Profile - Tracxn
Jun 17, 2025 Cellnovo is a deadpooled company based in London (United Kingdom), founded in 2002. It operates as a Smart device for diabetic management. Cellnovo has raised $48.4M in …See details»
CellNovo Company Profile - Office Locations, Competitors ... - Craft
Apr 29, 2020 See insights on CellNovo including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
French Diabetes Company Cellnovo Goes into Administration
Mar 29, 2019 Paris-based Cellnovo has cut down on staff as well as stopped manufacturing and selling its diabetes management system as the company found itself unable to scale up.See details»
Cellnovo Group: Revenue, Worth, Valuation & Competitors 2025
Cellnovo is an innovative medical technology company specialising in diabetes. The company develops and markets The Cellnovo System, the world's first mobile, connected, all-in-one …See details»
Cellnovo: Governance, Directors and Executives & Committees ...
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for …See details»
Cellnovo Insulin Pump - Diabetesnet.com
The Cellnovo Diabetes Management System includes an insulin patch pump, continuous activity monitor, and a cellular-enabled wireless touchscreen handset with integrated blood glucose …See details»
Cellnovo: Assisting People in the Pursuit of Healthy Lives
Cellnovo is leading the charge in this area with its Online Platform, which facilitates the capture and sharing of comprehensive information with clinicians and family members about the …See details»
Cellnovo: Shareholders Board Members Managers and Company …
Business description: Cellnovo Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development …See details»
[ 2024] Cellnovo Group SA Mckinsey 7S Analysis / Framework
Mickinsey 7S framework is used to analyze Cellnovo Group SA – competitive strategy, organization structure, human resources framework, culture, mission vision, and value …See details»
Cellnovo Group SA - insights.citeline.com
May 18, 2018 The global diabetes management devices market is expected to grow from $9bn in 2015 to $11.2bn by 2020, a CAGR of 4.5%. While blood glucose monitors – continuous or …See details»